Ropinirole for Restless Legs Syndrome
Ropinirole (Requip - GlaxoSmithKline), a dopamine agonist already available for treatment of Parkinson's disease, is now the first drug approved by the FDA for treatment of moderate to severe restless legs syndrome (RLS)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Ropinirole for Restless Legs Syndrome
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1214
Article Code: 1214b
Date: August 1, 2005
Volume: 47
Pages: 62-64
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1214
Article Code: 1214b
Date: August 1, 2005
Volume: 47
Pages: 62-64
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)